Is it Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now?
Edwards(EW) ZACKS·2024-12-13 15:15Edwards Lifesciences (EW) , following the sell-off of the Critical Care wing, looks forward to developing the most comprehensive structural heart portfolio. In TMTT, the robust adoption of the differentiated PASCAL technology is highly promising. The company is also advancing toward long-term growth through several initiatives across its businesses. Meanwhile, adverse macroeconomic impacts and currency fluctuations remain a concern for Edwards.In the past year, this Zacks Rank #3 (Hold) stock has dropped 1. ...